Kristen Hege
CIK 1299171 · VP Clinical Research · last filed 2026-01-06
Kristen Hege is a VP Clinical Research who has filed 27 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for MRSN, was dated Jan 6, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
5
27
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Mersana Therapeutics, Inc. (MRSN) Delisted | Director | 0 | $29.08 | $0 | $0 | 17 | 2026-01-06 |
| Adaptimmune Therapeutics PLC (ADAP) Delisted | Director | — | $0.06 | — | $0 | 2 | 2024-07-01 |
| LENZ Therapeutics, Inc. (GRPH) Delisted | Director | — | $22.26 | — | $0 | 2 | 2023-07-21 |
| RCUS | Director | — | $23.80 | — | $0 | 2 | 2019-06-10 |
| CELL GENESYS INC (CEGE) Delisted | VP Clinical Research | 27,512 | — | — | $0 | 4 | 2008-08-01 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-06 | Mersana Therapeutics, Inc. (MRSN) Delisted | Mixed | −578 | $0 | EDGAR |
| 2025-06-13 | Mersana Therapeutics, Inc. (MRSN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-07-01 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-06-12 | Mersana Therapeutics, Inc. (MRSN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-17 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-04 | Mersana Therapeutics, Inc. (MRSN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-10-04 | Mersana Therapeutics, Inc. (MRSN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-07-21 | LENZ Therapeutics, Inc. (GRPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-07-06 | Mersana Therapeutics, Inc. (MRSN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-12 | Mersana Therapeutics, Inc. (MRSN) Delisted | Grant (A) | +14,467 | $0 | EDGAR |